Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24622520 | 1.00 | SHBG (0.42) | SHBGEPHX1CTSKCYP1A2MEN1 | |
| SCHEMBL5460788 | 1.00 | SHBG (0.42) | SHBGEPHX1CTSKCYP1A2MEN1 | |
| SCHEMBL7392023 | 1.00 | SHBG (0.42) | SHBGEPHX1CTSKCYP1A2MEN1 | |
| SCHEMBL5479967 | 1.00 | SHBG (0.42) | SHBGEPHX1CTSKCYP1A2MEN1 | |
| SCHEMBL12817708 | 0.97 | SHBG (0.39) | SHBGEPHX1CTSKCYP1A2MEN1 | |
| SCHEMBL8075546 | 0.95 | SHBG (0.37) | SHBGCTSKCYP1A2MEN1KMT2A | |
| SCHEMBL4745186 | 0.92 | CTSK (0.34) | SHBGCTSKCYP1A2MEN1KMT2A | |
| SCHEMBL6620420 | 0.87 | CTSK (0.31) | CTSK | |
| SCHEMBL15578033 | 0.85 | SHBG (0.35) | SHBGEPHX1TP53 | |
| SCHEMBL8324336 | 0.85 | CPN1 (0.37) | SHBGEPHX1CYP1A2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1758859-B1 | GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES | LILLY CO ELI (US) | 2013-07-17 | — | — | EP | claimed |
| US-20080125468-A1 | Glucagon Receptor Antagonists, Preparation and Therapeutic Uses | ELI LILLY AND COMPANY | 2008-05-29 | — | — | US | claimed |
| US-6071910-A | Use of agents to treat eosinophil-associated pathologies | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2000-06-06 | — | — | US | claimed |
| EP-0208541-B1 | LUBRICANT COMPOSITIONS | NIPPON OIL CO. LTD. (JP) | 1991-12-04 | — | — | EP | claimed |
| US-20240246926-A1 | THIOEPOXY GROUP- AND (METH)ALLYL GROUP-CONTAINING COMPOUND, AND METHOD FOR PRODUCING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-25 | — | — | US | disclosed |
| EP-4342888-A1 | THIOEPOXY GROUP- AND (METH)ALLYL GROUP-CONTAINING COMPOUND, AND METHOD FOR PRODUCING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-03-27 | — | — | EP | disclosed |
| CN-117295723-A | Compound containing thiocpoxy group and (methyl) allyl group and process for producing the same | 信越化学工业株式会社 | 2023-12-26 | — | — | CN | disclosed |
| WO-2022244525-A1 | THIOEPOXY GROUP– AND (METH)ALLYL GROUP–CONTAINING COMPOUND, AND METHOD FOR PRODUCING SAME | 信越化学工業株式会社 | 2022-11-24 | — | — | WO | disclosed |
| CN-113880741-A | Method for producing isothiocyanate | 旭化成株式会社 | 2022-01-04 | — | — | CN | disclosed |
| CN-108350389-B | Lubricating grease for elevator sling, and traction elevator | 株式会社日立制作所 | 2021-06-15 | — | — | CN | disclosed |
| CN-106398810-B | The maintenance method of elevator cable lubricating grease, elevator cable, traction elevator and traction elevator | 株式会社日立制作所 | 2019-08-13 | — | — | CN | disclosed |
| CN-108350389-A | Lubricating grease for elevator sling, and traction elevator | 株式会社日立制作所 | 2018-07-31 | — | — | CN | disclosed |
| EP-2009304-A1 | TORQUE LIMITER | JTEKT Corporation (JP) | 2008-12-31 | — | — | EP | disclosed |
| EP-2003353-A1 | TORQUE LIMITER | JTEKT Corporation (JP) | 2008-12-17 | — | — | EP | disclosed |
| US-20050170146-A1 | Optical systems and refractive index-matching compositions | AVAGO TECHNOLOGIES GENERAL IP (SINGAPORE) PTE. LTD. (SG) | 2005-08-04 | — | — | US | disclosed |
| US-6890619-B2 | Optical systems and refractive index-matching compositions | AGILENT TECHNOLOGIES, INC. (US) | 2005-05-10 | — | — | US | disclosed |
| EP-0748863-A2 | Traction drive fluid composition | COSMO RESEARCH INSTITUTE (JP) | 1996-12-18 | — | — | EP | disclosed |
| EP-0208541-B1 | LUBRICANT COMPOSITIONS | NIPPON OIL CO. LTD. (JP) | 1991-12-04 | — | — | EP | disclosed |
| EP-0208541-A2 | Lubricant compositions | NIPPON OIL CO. LTD. (JP) | 1987-01-14 | — | — | EP | disclosed |
| EP-0000757-A1 | Process for the preparation of triarylphosphites | CIBA-GEIGY AG (CH) | 1979-02-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240246926-A1 | THIOEPOXY GROUP- AND (METH)ALLYL GROUP-CONTAINING COMPOUND, AND METHOD FOR PRODUCING SAME | TET1, TST, MGMT | SHBG 689/4885EPHX1 2179/4885CTSK 4814/4885 |
| US-20080125468-A1 | Glucagon Receptor Antagonists, Preparation and Therapeutic Uses | GLP1R, GCGR, GIPR | SHBG 153/4885EPHX1 2400/4885CTSK 3997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.